0.97
+0.0792(+8.89%)
Currency In USD
| Previous Close | 0.89 |
| Open | 0.91 |
| Day High | 1.01 |
| Day Low | 0.9 |
| 52-Week High | 4.28 |
| 52-Week Low | 0.49 |
| Volume | 652,333 |
| Average Volume | 685,790 |
| Market Cap | 45.35M |
| PE | -1.24 |
| EPS | -0.78 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 1.28 |
| Change | 0.08 |
If you invested $1000 in Reviva Pharmaceuticals Holdings, Inc. (RVPH) since IPO date, it would be worth $99.92 as of June 01, 2025 at a share price of $0.97. Whereas If you bought $1000 worth of Reviva Pharmaceuticals Holdings, Inc. (RVPH) shares 5 years ago, it would be worth $92.05 as of June 01, 2025 at a share price of $0.97.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Reviva to Participate in Upcoming Investor Conferences in May 2025
GlobeNewswire Inc.
May 20, 2025 12:00 PM GMT
CUPERTINO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of
Reviva to Participate in the A.G.P. Healthcare Company Showcase
GlobeNewswire Inc.
May 13, 2025 12:00 PM GMT
CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of
Reviva to Participate in the Citizens Life Sciences Conference
GlobeNewswire Inc.
Apr 29, 2025 12:00 PM GMT
CUPERTINO, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas o